HR Digest

MARCH 8, 2020

They offer hosting and management services, along with marketing and customer service management. It conducts clinical trials on behalf of its pharmaceutical clients and provides regulatory, consulting, and market access to expedite the drug approval process. It offers Linux, cloud, container, and Kubernetes technologies.

Company 85

Company Insurance Travel Software 85

Tanveer Naseer

MARCH 10, 2015

For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” In other words, Larry Page sees Google as a broad portfolio of science, technology, and Internet-related resources that can be leveraged into almost any meaningful new venture. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

N2Growth Blog

FEBRUARY 4, 2015

Here is the rub and the reason why adopting this principle is so critical: in our experience, the priority initiatives turn out to be on new product, service, customer, and technology initiatives accompanied by an assumption that the organization has the capabilities to execute them. Engineered to Win.

Process 150

Process Agility Competitive Advantage Strategy 150

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

MAY 7, 2015

Recently, information technology research and advisory company Gartner compiled a list of top 10 strategic technology trends. This information improved marketing campaign targeting, as well as sales force targeting. In the pharmaceutical industry, technology is transforming the sales process. Computing everywhere.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

JULY 17, 2014

When Raja Rajamannar became CMO of MasterCard Worldwide in 2013, he moved quickly to transform how the credit card giant measures marketing. But the real power and full potential of data was not being fully realized by marketing. As an ingredient brand, Intel often struggled to link marketing to P&L impact. Inside Intel.

Finance 13

Finance Marketing P&L ROI 13

Harvard Business Review

OCTOBER 14, 2016

Much of marketing is premised on companies delivering messages to customers to influence their purchases and consumption. Indeed, the largest advertisers in the world are companies such as Procter & Gamble, Nestlé, and Unilever, which sell branded low-involvement products that are routinely purchased and consumed at a regular pace.

Marketing 8

Marketing Advertising Loyalty Retail 8

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. To understand the nature of the problem, let’s look at how penicillin was brought to market. There is a wide chasm that separates an initial discovery and a viable product idea.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. Regulatory environment.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

NOVEMBER 24, 2016

This is particularly true for the marketing department, which is changing at such a break-neck pace that marketing success now depends heavily on support from HR to identify and train new skillsets. On the flip side, success in HR could use a major assist from marketing, or at least HR professionals who think like marketers.

Marketing 8

Marketing Content Pharmaceuticals PR 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

AUGUST 14, 2018

Many leading American digital firms, including Google, Amazon, eBay, and Uber, have successfully expanded internationally by introducing their products, services, and platforms in other countries. However, they have all failed in China, the world’s largest digital market. imposing technological platforms developed for the U.S.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 10

Pharmaceuticals Banking Chemicals Trends 10

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." You don’t cut prices by 90% through marginal improvements in existing products. The numbers are enough to make the apple pop right out of the marketer's eye. Looking to take an unsuspecting industry by storm?

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

MAY 10, 2018

But China also has a huge domestic market for fake goods: many consumers who buy counterfeits do so deliberately, because they want to pay a lower price for goods that look expensive. Do not wait until you actually enter the Chinese market. A store that guarantees the authenticity of all products it sells is a big relief for them.

Brand 8

Brand Supply Chain Merchandising Tactics 8

Harvard Business Review

OCTOBER 26, 2017

Today when we talk about business “ clusters ,” we’re usually talking about the technology industry in Silicon Valley, the financial sector in London or New York, or automakers in southern Germany. In the early 1920s, as a result of a growing market for Idrolitina, Gazzoni decided to automate the packaging process.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

JULY 4, 2017

With that in mind, I can see three potential scenarios for how Apple might play in the autonomous car market. The second play is to try to use its technological aptitude to create a vehicle that solves a particular problem. Some of them may never enter the car market, or may at least significantly delay a move toward ownership.

Transportation 9

Transportation Sports Pharmaceuticals Health Care 9

Harvard Business Review

MAY 26, 2016

Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. If so, then high profits portend diminished productivity growth. Smaller regulatory changes are also associated with a subsequent rise in firm market values and profits.

Pharmaceuticals 10

Pharmaceuticals Politics Price Chemicals 10

Harvard Business Review

MARCH 31, 2016

” In the article, a marketing expert explains why societal shifts would render the door-to-door salesman obsolete. Buyers usually first became aware of new products when a traveling salesman showed up at the door. Today, buyers increasingly use the web to evaluate purchase options in both B2C and B2B markets.

B2B 8

B2B B2C Uncertainty Self-aware 8

Harvard Business Review

APRIL 19, 2016

Carmakers have started using 3D technology to produce parts. Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. The technology is expected to lead to reductions in the cost of employment, capital investment, shipping and inventory as well.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. So reducing investments in low-value care services means spending less on doctors, hospitals, and other health care technologies. rawpixel/Getty Images.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 27, 2018

The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power. He noted his agency’s “particular concerns in digital markets.” Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. Lower-quality products with less privacy.

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

AUGUST 3, 2012

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. As yet, the facts don't seem to substantiate the fears.

Licensing 13

Licensing Depreciation Pharmaceuticals Budgeting 13

Harvard Business Review

OCTOBER 26, 2011

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 12, 2012

His company is quite respected in the sustainability community both for its progressive social equity policies and for green technology that limits the environmental impacts of his company's manufacturing activities. So I asked: Do you foresee a time when you'd willingly provide access to your leading green technology to your competitors?

Co-Opetition 14

Co-Opetition Company Brandenburger Game Theory 14

Harvard Business Review

JANUARY 27, 2016

Historically, the place we’ve looked for hints of oncoming disruptions has been in the low end of the market. Because disruptive products were cheaper, more accessible, and built on new technology architectures, they tended to be crummier than the existing highest-end solutions. Instead, it was a byproduct.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Demand is Shifting.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

NOVEMBER 8, 2017

The health care system in the United States, with its technological prowess and massive infrastructure, often serves as a reference point for rapidly developing economies around the world while they build their own medical systems. Over the same period, pharmaceutical exports have doubled. Insight Center. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." You don’t cut prices by 90% through marginal improvements in existing products. The numbers are enough to make the apple pop right out of the marketer's eye. Looking to take an unsuspecting industry by storm?

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

SEPTEMBER 14, 2017

A less aggressive mix (say 75:25) is typical in industries such as pharmaceuticals that want salespeople to focus on customer education, and for technical sales jobs that have a large problem-solving component. Products such as chronic care medications have high carryover. Franchise sales have nothing to do with salespeople.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. Are we going to have to work really hard to differentiate the product or products that result from the acquisition? billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13